[go: up one dir, main page]

ES535188A0 - Procedimiento para la preparacion de alfa-aminoacidos alfa-alenicos - Google Patents

Procedimiento para la preparacion de alfa-aminoacidos alfa-alenicos

Info

Publication number
ES535188A0
ES535188A0 ES535188A ES535188A ES535188A0 ES 535188 A0 ES535188 A0 ES 535188A0 ES 535188 A ES535188 A ES 535188A ES 535188 A ES535188 A ES 535188A ES 535188 A0 ES535188 A0 ES 535188A0
Authority
ES
Spain
Prior art keywords
alpha
amino acids
alenicos
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES535188A
Other languages
English (en)
Other versions
ES8601853A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of ES8601853A1 publication Critical patent/ES8601853A1/es
Publication of ES535188A0 publication Critical patent/ES535188A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
ES535188A 1983-08-17 1984-08-16 Procedimiento para la preparacion de alfa-aminoacidos alfa-alenicos Granted ES535188A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52447683A 1983-08-17 1983-08-17

Publications (2)

Publication Number Publication Date
ES8601853A1 ES8601853A1 (es) 1985-12-01
ES535188A0 true ES535188A0 (es) 1985-12-01

Family

ID=24089362

Family Applications (3)

Application Number Title Priority Date Filing Date
ES535188A Granted ES535188A0 (es) 1983-08-17 1984-08-16 Procedimiento para la preparacion de alfa-aminoacidos alfa-alenicos
ES545497A Expired ES8701149A1 (es) 1983-08-17 1985-07-23 Procedimiento para la preparacion de alfa-aminoacidos alfa- alenicos
ES545496A Expired ES8702338A1 (es) 1983-08-17 1985-07-23 Procedimiento para la preparacion de alfa-aminoacidos alfa- alenicos

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES545497A Expired ES8701149A1 (es) 1983-08-17 1985-07-23 Procedimiento para la preparacion de alfa-aminoacidos alfa- alenicos
ES545496A Expired ES8702338A1 (es) 1983-08-17 1985-07-23 Procedimiento para la preparacion de alfa-aminoacidos alfa- alenicos

Country Status (15)

Country Link
EP (1) EP0134561B1 (es)
JP (1) JPS6089459A (es)
KR (1) KR900001182B1 (es)
AT (1) ATE28186T1 (es)
AU (1) AU571559B2 (es)
CA (1) CA1242203A (es)
DE (1) DE3464599D1 (es)
DK (1) DK394284A (es)
ES (3) ES535188A0 (es)
FI (1) FI843245A7 (es)
HU (1) HU194808B (es)
IL (1) IL72703A (es)
NO (1) NO168352C (es)
NZ (1) NZ209250A (es)
ZA (1) ZA846388B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3075809U (ja) * 2000-08-23 2001-03-06 新世代株式会社 カラオケ用マイク

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT319993B (de) * 1971-07-14 1975-01-27 Plasser Bahnbaumasch Franz Fahrbare Gleisnivellier-Stopfmaschine
US3855271A (en) * 1973-12-20 1974-12-17 Lilly Co Eli 2-amino-2-allenylmalonic esters
US4178463A (en) * 1978-01-30 1979-12-11 Merrell Toraude Et Compagnie Process for making 4-aminohex-5-enoic acid
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
GB2120244B (en) * 1982-05-17 1985-05-01 Merrell Toraude & Co Aminoalkadiene derivative

Also Published As

Publication number Publication date
ES545497A0 (es) 1986-12-01
JPS6089459A (ja) 1985-05-20
ES545496A0 (es) 1987-01-16
NO843273L (no) 1985-02-18
NZ209250A (en) 1988-11-29
ES8601853A1 (es) 1985-12-01
ES8701149A1 (es) 1986-12-01
ATE28186T1 (de) 1987-07-15
ZA846388B (en) 1986-03-26
DE3464599D1 (de) 1987-08-13
IL72703A0 (en) 1984-11-30
CA1242203A (en) 1988-09-20
IL72703A (en) 1988-11-15
KR900001182B1 (ko) 1990-02-27
ES8702338A1 (es) 1987-01-16
NO168352C (no) 1992-02-12
DK394284D0 (da) 1984-08-16
KR850001900A (ko) 1985-04-10
HUT34950A (en) 1985-05-28
FI843245A0 (fi) 1984-08-16
EP0134561A1 (en) 1985-03-20
EP0134561B1 (en) 1987-07-08
AU3200584A (en) 1985-02-21
HU194808B (en) 1988-03-28
DK394284A (da) 1985-02-18
NO168352B (no) 1991-11-04
AU571559B2 (en) 1988-04-21
FI843245A7 (fi) 1985-02-18

Similar Documents

Publication Publication Date Title
DE3689727D1 (de) Granulierungsverfahren für enzyme.
MX162265A (es) Procedimiento mejorado para la preparacion de acido 4-dimetilamino-1-hidro-xibutano-1,1-difosfonico
FI915093A0 (fi) Sackarinderivat anvaendbara som inhibitorer foer proteolytiskt enzym och deras framstaellning.
ES517408A0 (es) Procedimiento para la preparacion de biocatalizadores de actividad enzimatica.
IT8420574A0 (it) Metodo per il trattamento enzimatico di polpa pre-spremuta.
ES518477A0 (es) Procedimiento para la produccion de dihidrofuropiridinonas cromogenas.
ES504384A0 (es) Procedimiento para la produccion de la enzima colesterol-es-terasa
AR222747A1 (es) Procedimiento para la produccion de enzima de fructosil transferasa
ES535188A0 (es) Procedimiento para la preparacion de alfa-aminoacidos alfa-alenicos
ES533079A0 (es) Procedimiento para la determinacion cuantitativa de la enzima c1 esterasa.
DK428184A (da) 2-oxocarbonsyrereduktase, fremgangsmaade til fremstilling heraf samt anvendelse heraf til reduktion af 2-oxocarbonsyrer og disses estere
IT8520090A0 (it) Procedimento di purificazione di un enzima.
ES549459A0 (es) Un procedimiento para la preparacion de derivados enzimaticos.
ES550351A0 (es) Procedimiento para la produccion de 8-alfa-acilamino-ergolinas.
IT8121442A0 (it) Procedimento per produrre l-amminoacido ossidasi.
AR240317A1 (es) Procedimiento para la preparacion de pirimidinatrionas n-monosubtituidas-5,5-disubtituidas.
IT8025518A0 (it) Procedimento per la produzione di acil-coa ossidasi.
ES512700A0 (es) Procedimiento para la preparacion de inhibidores de monoamina oxidasa.
FI844395A7 (fi) Katalyyttinen menetelmä kalsiumkarbonaatin kiihdytettyä dekarboksyloin tia varten ja seos tätä varten.
ES524706A0 (es) Procedimiento para la preparacion de n-(2-piridil)-(1,4-dimetil-5-(4-clorobenzoil))-2-pirrolacetamida.
ES543408A0 (es) Metodo para la determinacion cuantitativa de enzimas.
ES519604A0 (es) Procedimiento para la fabricacion de calzados.
NO156654C (no) Fremgangsmaate for enzymatisk erstatning av b-30-aminosyren i insuliner.
MX7414E (es) Procedimiento enzimatico para la preparacion de hidrolizados de proteinas
ES538692A0 (es) Procedimiento para la preparacion de 9alfa-cloro-11beta-hidroxi-16beta-metil-1,4-preguaddien-3,20-diona-17-propionato-21-(-2-hidroxibenzoato).

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603